Office Room #: 101
160 Frelinghuysen Road, Piscataway, NJ 08854
Christopher J. Molloy, PhD
Pharmacology and Toxicology
Education & TrainingPhD - Toxicology - Rutgers University and UMDNJ, Piscataway, NJ
BS - Pharmacy - Rutgers University, New Brunswick, NJ
Post-Doctoral Fellowship - NIH, National Cancer Institute, Bethesda, MD
CertificationsRegistered Pharmacist (NJ) 1977 - present
Research InterestsDr. Molloy is a molecular and cellular pharmacologist with extensive drug discovery research and management experience in the biopharmaceutical industry. As an industry scientist, he led multidisciplinary drug discovery teams that have advanced new chemical entities from conception into human clinical trials in therapeutic areas such as inflammation, oncology, and cardiovascular disease. He is a member of the Rutgers Cancer Institute of New Jersey.
Scholarly ActivitiesChristopher J. Molloy joined Rutgers in 2007 as dean of the Ernest Mario School of Pharmacy. In 2011, he was appointed interim provost for biomedical and health sciences and successfully managed the complex integration of Rutgers with most of the former University of Medicine and Dentistry of New Jersey (UMDNJ) that was completed in July, 2013. Molloy briefly served as interim chancellor of Rutgers Biomedical and Health Sciences and then Senior Vice President for the Office of Research and Economic Development until his appointment as Chancellor in July, 2018.
Molloy received his bachelor’s degree in pharmacy from Rutgers and his doctoral degree from the joint Rutgers Graduate School of Biomedical Sciences at Robert Wood Johnson Medical School/Graduate School–New Brunswick. He was a post-doctoral fellow at the National Cancer Institute.
Prior to joining Rutgers, Molloy held senior research and management positions at Johnson & Johnson, 3-Dimensional Pharmaceuticals Inc., and Bristol-Myers Squibb Pharmaceutical Research Institute. He is also a licensed pharmacist in New Jersey. At Rutgers, he holds a faculty position as Distinguished Professor of Pharmacology and Toxicology and is a member of the Rutgers Cancer Institute of New Jersey, the American Association for Cancer Research, and the American Society for Biochemistry and Molecular Biology, and the American Pharmacists Association. He was elected as a Fellow of the American Association for the Advancement of Science in 2016.
Awards2016 - Fellow, American Association for Advancement of Science
2016 - NJ Manufacturing Extension Program’s Honor Roll for Manufacturing and STEM
2013 - Healthcare Institute of New Jersey (HINJ), Special Recognition Award
2013 - NJBiz Power 50 Health Care (2012-2013)
2011 - New Jersey Pharmacists Association, Presidential Citation Award
2009 - Distinguished Alumnus Award, Graduate School of Biomedical Sciences
2006 - Standards of Leadership Award, Johnson and Johnson
2004 - Excellence in Science Award, Johnson and Johnson Pharm. Res. and Develop. LLC
1991 - Molloy et al., Nature 342: 711,1989 designated "Hot Paper" in The Scientist V5, p.15
1990 - Spanish Health Ministry Visiting Fellowship Award, Madrid, Spain
1986 - Biotechnology Fellowship Award, National Cancer Institute
1983 - Graduate Fellowship Award, Society of Cosmetic Chemists